Holen Sie sich die Stockscreener-App
134.28
0.01%
0.02
Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten
Why Wall Street Can't Get Enough of This Dividend King - The Motley Fool
Form 4 Apogee Therapeutics Inc For: 24 July By Investing.com - Investing.com Canada
Apogee Therapeutics (APGE) CFO makes bona fide gift of 15,000 shares - Stock Titan
Understanding Momentum Shifts in (APGE) - Stock Traders Daily
Apogee Therapeutics stock hits all-time high at 134.34 USD - Investing.com
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend? - Yahoo Finance
Apogee Therapeutics (APGE) Proxy filing Summary - Quartr
Form 4 Apogee Therapeutics Inc For: 16 July By Investing.com - Investing.com South Africa
Apogee Therapeutics (APGE) CMO donates 8,000 shares to donor advised fund - Stock Titan
MSN Money - MSN
FMR LLC Significantly Reduces Stake in Apogee Therapeutics Inc. - GuruFocus
Apogee Therapeutics stock hits all-time high at 133.88 USD By Investing.com - Investing.com South Africa
AbbVie, Apogee Therapeutics filed HSR July 6, setting up Aug. 5 expiration - MLex
Apogee Therapeutics (NASDAQ: APGE) backs AbbVie’s $135.11‑per‑share all‑cash deal - Stock Titan
Apogee Therapeutics stock hits all-time high at 133.88 USD - Investing.com
What This Apogee Insider Move Might Mean After a 247% Stock Run - The Motley Fool
Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock By Investing.com - Investing.com India
Form 4 Apogee Therapeutics Inc For: 10 July By Investing.com - Investing.com Australia
CEO Michael Henderson Sells 20,000 Shares of Apogee Therapeutics Inc (APGE) - GuruFocus
Apogee Therapeutics CEO Michael Henderson sells $2.67m in stock - Investing.com
Apogee Therapeutics (APGE) CEO logs stock sale and 75,046-share charitable gift - Stock Titan
Apogee Therapeutics (APGE) Jumps Into Focus, Is The Stock Fully Valued? - Yahoo Finance
Blackstone pledges $1.3 billion to help develop Apogee skin drug - MSN
AbbVie files $10.9bn Apogee deal in Germany - MLex
AbbVie to buy Apogee Therapeutics for $10.9 billion in cash - MSN
Wellington-affiliates report 564,326 APGE shares (APGE) ownership update - Stock Titan
T. Rowe Price boosts Apogee Therapeutics holding to 772,969 shares (NASDAQ: APGE) - Stock Titan
FMR LLC reports 2.49M Apogee Therapeutics shares (NASDAQ: APGE) - Stock Titan
Enterprise value to EBIT forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
Price to earnings forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
My Takeaway On Apogee Therapeutics' Massive Cash Raise Humberto Cruz (GVA0ZiS739) - Mshale
Price to earnings forward of Apogee Therapeutics, Inc. – BOATS:APGE - TradingView
Apogee Therapeutics: My Take On Their Promising Eczema Drug Data Kb5089549 (eYX66guJPl) - Mshale
Enterprise value to EBITDA forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
Price to book forward of Apogee Therapeutics, Inc. – NASDAQ:APGE - TradingView
Apogee Therapeutics: AbbVie Acquisition And Merger Arbitrage Analysis APGE $APGE #APGE #stockmarket Diana Shnaider (BwfgwfruEs) - Mshale
Apogee Therapeutics | SCHEDULE 13G/A: Others - Moomoo
Apogee Therapeutics CMO Carl Dambkowski sells $730,070 in stock By Investing.com - Investing.com Australia
Form 4 Apogee Therapeutics Inc For: 2 July By Investing.com - Investing.com Nigeria
Apogee Therapeutics CMO Carl Dambkowski sells $730,070 in stock - Investing.com
Apogee Therapeutics (APGE) CMO sells shares, exercises options under 10b5-1 plan - Stock Titan
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl - Moomoo
APGEApogee Therapeutics Inc Revenue Breakdown - Finviz
AbbVie to buy Apogee Therapeutics (APGE) for $135.11 per share — significant premium - Stock Titan
Apogee Therapeutics stock hits all-time high at 133.32 USD By Investing.com - Investing.com Australia
Apogee Therapeutics stock hits all-time high at 133.32 USD - Investing.com
AbbVie shares fell after six-session winning streak - MSN
Form 144 APOGEE THERAPEUTICS INC For: 1 July By Investing.com - Investing.com Canada
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News - Insider Monkey
0.46%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):